Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany

ConclusionCM-chitosan showed a rapid onset of pain relief after 1  week and with a duration of 9 months. In a real-world setting, treatment with CM-chitosan would appear to be a potentially effective option to reduce pain and improve physical function and global condition in patients with knee OA, opening new perspectives in patients who are considered as refrac tory to current symptomatic therapies and where the unmet need is high.Trial Registration NumberNCT04757051 (ClinicalTrials.gov).
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research